| TTNP | Titan Pharmaceuticals Inc (de) | $263000.00 | -95.96% |
| LEXX | Lexaria Bioscience Corp | $276997.00 | -95.75% |
| CELZ | Creative Medical Technology Holdings Inc | $307649.00 | -95.27% |
| BBLG | Bone Biologics Corp | $309386.00 | -95.25% |
| CURX | Curanex Pharmaceuticals Inc | $332644.00 | -94.89% |
| ORMP | Oramed Pharmaceuticals Inc | $502688.00 | -92.28% |
| TCRT | Alaunos Therapeutics Inc | $595000.00 | -90.86% |
| VRAX | Virax Biolabs Group Ltd - Class A | $641516.00 | -90.15% |
| CDIO | Cardio Diagnostics Holdings Inc | $655972.00 | -89.92% |
| GRI | GRI Bio Inc | $794000.00 | -87.80% |
| BGMS | Bio Green Med Solution Inc | $804000.00 | -87.65% |
| XRTX | XORTX Therapeutics Inc | $863819.00 | -86.73% |
| NTRB | Nutriband Inc | $868447.00 | -86.66% |
| PULM | Pulmatrix Inc | $905000.00 | -86.10% |
| PBM | Psyence Biomedical Ltd | $943068.00 | -85.51% |
| PHIO | Phio Pharmaceuticals Corp | $950000.00 | -85.41% |
| LITS | Lite Strategy Inc | $952000.00 | -85.38% |
| XBIO | Xenetic Biosciences Inc | $958239.00 | -85.28% |
| DRMA | Dermata Therapeutics Inc | $1.05M | -83.83% |
| CVKD | Cadrenal Therapeutics Inc | $1.06M | -83.64% |
| NNVC | NanoViricides Inc | $1.10M | -83.10% |
| GDTC | CytoMed Therapeutics Ltd | $1.13M | -82.62% |
| VYNE | VYNE Therapeutics Inc | $1.24M | -81.01% |
| OGEN | Oragenics Inc | $1.31M | -79.91% |
| SILO | SILO Pharma Inc | $1.34M | -79.47% |
| ANIX | Anixa Biosciences Inc | $1.39M | -78.69% |
| SYBX | Synlogic Inc | $1.42M | -78.16% |
| TELO | Telomir Pharmaceuticals Inc | $1.43M | -78.06% |
| HOTH | Hoth Therapeutics Inc | $1.43M | -77.99% |
| CMMB | Chemomab Therapeutics Ltd | $1.48M | -77.30% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $1.49M | -77.18% |
| ADIL | Adial Pharmaceuticals Inc | $1.51M | -76.80% |
| KTTA | Pasithea Therapeutics Corp | $1.54M | -76.31% |
| KALA | Kala Bio Inc | $1.56M | -76.08% |
| ADXN | Addex Therapeutics Ltd | $1.60M | -75.43% |
| EPIX | Essa Pharma Inc | $1.60M | -75.42% |
| GLSI | Greenwich LifeSciences Inc | $1.62M | -75.08% |
| AZTR | Azitra Inc | $1.65M | -74.71% |
| KAPA | Kairos Pharma Ltd | $1.67M | -74.32% |
| LIXT | Lixte Biotechnology Holdings Inc | $1.69M | -74.09% |
| ALZN | Alzamend Neuro Inc | $1.86M | -71.47% |
| BIVI | BioVie Inc - Class A | $1.91M | -70.71% |
| PCSA | Processa Pharmaceuticals Inc | $1.98M | -69.58% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $2.02M | -68.99% |
| REVB | Revelation Biosciences Inc | $2.06M | -68.43% |
| IMRN | Immuron Ltd | $2.06M | -68.37% |
| HIND | ReShape Lifesciences Inc | $2.14M | -67.06% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $2.21M | -66.09% |
| INDP | Indaptus Therapeutics Inc | $2.24M | -65.65% |
| INTS | Intensity Therapeutics Inc | $2.31M | -64.49% |
| EDSA | Edesa Biotech Inc | $2.36M | -63.74% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $2.38M | -63.52% |
| ENTX | Entera Bio Ltd | $2.44M | -62.49% |
| GOVX | Geovax Labs Inc | $2.49M | -61.77% |
| EXOZ | Invizyne Technologies Inc | $2.49M | -61.74% |
| VIVS | VivoSim Labs Inc | $2.52M | -61.31% |
| ACXP | Acurx Pharmaceuticals Inc | $2.53M | -61.19% |
| LPCN | Lipocine Inc | $2.53M | -61.17% |
| NRSN | NeuroSense Therapeutics Ltd | $2.59M | -60.25% |
| MNPR | Monopar Therapeutics Inc | $2.59M | -60.23% |
| PTN | Palatin Technologies Inc | $2.63M | -59.55% |
| ATHE | Alterity Therapeutics Ltd | $2.65M | -59.32% |
| RNXT | RenovoRx Inc | $2.70M | -58.54% |
| KZR | Kezar Life Sciences Inc | $2.76M | -57.57% |
| BCDA | BioCardia Inc | $2.78M | -57.33% |
| ENSC | Ensysce Biosciences Inc | $2.84M | -56.42% |
| MTNB | Matinas Biopharma Holdings Inc | $2.85M | -56.19% |
| CMND | Clearmind Medicine Inc | $2.90M | -55.40% |
| LIMN | Liminatus Pharma Inc | $2.92M | -55.10% |
| NRXS | Neuraxis Inc | $3.00M | -53.95% |
| IGC | IGC Pharma Inc | $3.06M | -52.93% |
| ONCO | Onconetix Inc | $3.08M | -52.63% |
| ASBP | Aspire Biopharma Holdings Inc | $3.25M | -50.10% |
| MNOV | Medicinova Inc | $3.30M | -49.35% |
| COCP | Cocrystal Pharma Inc | $3.31M | -49.16% |
| FBLG | FibroBiologics Inc | $3.34M | -48.73% |
| GNPX | Genprex Inc | $3.38M | -48.14% |
| LSTA | Lisata Therapeutics Inc | $3.39M | -47.97% |
| BDRX | Biodexa Pharmaceuticals Plc | $3.39M | -47.96% |
| INAB | IN8bio Inc | $3.48M | -46.48% |
| GRCE | Acasti Pharma Inc | $3.60M | -44.76% |
| EQ | Equillium Inc | $3.60M | -44.76% |
| MRKR | Marker Therapeutics Inc | $3.64M | -44.12% |
| PPCB | Propanc Biopharma Inc | $3.66M | -43.79% |
| BNTC | Benitec Biopharma Inc | $3.67M | -43.66% |
| BRTX | BioRestorative Therapies Inc | $3.67M | -43.61% |
| ERNA | Ernexa Therapeutics Inc | $3.68M | -43.41% |
| LTRN | Lantern Pharma Inc | $3.78M | -41.98% |
| DRUG | Bright Minds Biosciences Inc | $3.83M | -41.17% |
| SNGX | Soligenix Inc | $3.83M | -41.13% |
| CANF | Can-Fite Biopharma Ltd | $3.92M | -39.75% |
| ICU | SeaStar Medical Holding Corp | $3.95M | -39.35% |
| APRE | Aprea Therapeutics Inc | $3.95M | -39.31% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $4.10M | -37.07% |
| PHGE | BiomX Inc | $4.13M | -36.53% |
| NCEL | NLS Pharmaceutics Ltd | $4.20M | -35.56% |
| RLYB | Rallybio Corp | $4.20M | -35.56% |
| CDT | CDT Equity Inc | $4.27M | -34.35% |
| CLYM | Eliem Therapeutics Inc | $4.29M | -34.15% |
| COYA | Coya Therapeutics Inc | $4.30M | -33.94% |
| SLXN | Silexion Therapeutics Corp | $4.31M | -33.78% |
| CRVO | CervoMed Inc | $4.50M | -30.92% |
| SLRX | Decoy Therapeutics Inc | $4.55M | -30.17% |
| CNSP | Cns Pharmaceuticals Inc | $4.58M | -29.61% |
| GTBP | GT Biopharma Inc | $4.60M | -29.34% |
| CLDI | Calidi Biotherapeutics Inc | $4.66M | -28.48% |
| IMNN | Imunon Inc | $4.66M | -28.43% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.70M | -27.74% |
| GANX | Gain Therapeutics Inc | $4.73M | -27.32% |
| XBIT | XBiotech Inc | $4.82M | -25.98% |
| APM | Aptorum Group Ltd - Class A | $4.90M | -24.73% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $4.92M | -24.37% |
| CLRB | Cellectar Biosciences Inc | $5.06M | -22.29% |
| ACTU | Actuate Therapeutics Inc | $5.13M | -21.25% |
| LGVN | Longeveron Inc - Class A | $5.18M | -20.38% |
| NCNA | NuCana plc | $5.19M | -20.33% |
| MTVA | MetaVia Inc | $5.32M | -18.36% |
| NEUP | Neuphoria Therapeutics Inc | $5.39M | -17.28% |
| EPRX | Eupraxia Pharmaceuticals Inc | $5.70M | -12.38% |
| IKT | Inhibikase Therapeutics Inc | $5.71M | -12.26% |
| ANTX | AN2 Therapeutics Inc | $5.73M | -11.95% |
| ARTL | Artelo Biosciences Inc | $5.85M | -10.20% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $5.93M | -8.86% |
| PALI | Palisade Bio Inc | $5.95M | -8.56% |
| SPRO | Spero Therapeutics Inc | $6.09M | -6.50% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $6.12M | -6.00% |
| INMB | INmune Bio Inc | $6.19M | -4.85% |
| CGTX | Cognition Therapeutics Inc | $6.23M | -4.32% |
| STTK | Shattuck Labs Inc | $6.29M | -3.44% |
| AVXL | Anavex Life Sciences Corporation | $6.37M | -2.14% |
| ELAB | PMGC Holdings Inc | $6.45M | -0.96% |
| ONCT | Oncternal Therapeutics Inc | $6.45M | -0.88% |
| MREO | Mereo Biopharma Group Plc | $6.56M | +0.77% |
| CNTX | Context Therapeutics Inc | $6.66M | +2.25% |
| PMN | ProMIS Neurosciences Inc | $6.69M | +2.83% |
| JUNS | Jupiter Neurosciences Inc | $6.73M | +3.41% |
| SLS | SELLAS Life Sciences Group Inc | $6.76M | +3.92% |
| EVGN | Evogene Ltd | $6.81M | +4.59% |
| PTIX | Protagenic Therapeutics Inc | $6.82M | +4.82% |
| ABVC | ABVC BioPharma Inc | $6.90M | +6.05% |
| QNRX | Quoin Pharmaceuticals Ltd | $6.92M | +6.29% |
| SLGL | Sol-Gel Technologies Ltd | $7.11M | +9.16% |
| SGMT | Sagimet Biosciences Inc - Class A | $7.18M | +10.29% |
| THRD | Third Harmonic Bio Inc | $7.21M | +10.83% |
| RNTX | Rein Therapeutics Inc | $7.24M | +11.21% |
| ENVB | Enveric Biosciences Inc | $7.25M | +11.42% |
| KPRX | Kiora Pharmaceuticals Inc | $7.29M | +12.02% |
| ATOS | Atossa Therapeutics Inc | $7.46M | +14.55% |
| TRVI | Trevi Therapeutics Inc | $7.48M | +14.88% |
| MAIA | MAIA Biotechnology Inc | $7.56M | +16.13% |
| PSTV | Plus Therapeutics Inc | $7.96M | +22.20% |
| MBIO | Mustang Bio Inc | $7.99M | +22.67% |
| OKYO | OKYO Pharma Ltd - New | $8.06M | +23.80% |
| MBRX | Moleculin Biotech Inc | $8.18M | +25.65% |
| HYFT | MindWalk Holdings Corp | $8.19M | +25.81% |
| DYAI | Dyadic International Inc DE | $8.22M | +26.23% |
| KLTO | Klotho Neurosciences Inc Com | $8.27M | +27.01% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $8.27M | +27.01% |
| APVO | Aptevo Therapeutics Inc | $8.29M | +27.34% |
| IMRX | Immuneering Corp Class A | $8.29M | +27.37% |
| IBIO | iBio Inc | $8.30M | +27.45% |
| VERU | Veru Inc | $8.30M | +27.45% |
| TENX | Tenax Therapeutics Inc | $8.49M | +30.35% |
| PMVP | PMV Pharmaceuticals Inc | $8.60M | +32.03% |
| RZLT | Rezolute Inc | $8.63M | +32.49% |
| ESLA | Estrella Immunopharma Inc | $8.93M | +37.14% |
| CUE | Cue Biopharma Inc | $9.27M | +42.38% |
| ABP | Abpro Holdings, Inc Common Stock | $9.35M | +43.55% |
| GNLX | Genelux Corp | $9.45M | +45.18% |
| SER | AgeX Therapeutics Inc | $9.67M | +48.56% |
| CALC | CalciMedica Inc | $9.71M | +49.20% |
| APLM | Apollomics Inc - Class A | $9.90M | +52.10% |
| TPST | Tempest Therapeutics Inc | $9.93M | +52.47% |
| IMAB | I-Mab | $9.97M | +53.23% |
| BLTE | Belite Bio Inc | $10.07M | +54.69% |
| TRML | Tourmaline Bio Inc | $10.10M | +55.19% |
| XCUR | Exicure Inc | $10.12M | +55.38% |
| SKYE | Skye Bioscience Inc | $10.40M | +59.83% |
| EVAX | Evaxion Biotech A/S | $10.44M | +60.29% |
| MURA | Mural Oncology plc | $10.57M | +62.40% |
| TARA | Protara Therapeutics Inc | $10.71M | +64.59% |
| QNCX | Quince Therapeutics Inc | $10.95M | +68.22% |
| WHWK | Whitehawk Therapeutics Inc | $11.06M | +69.83% |
| NVCT | Nuvectis Pharma Inc | $11.18M | +71.71% |
| TRAW | Traws Pharma Inc | $11.25M | +72.75% |
| NXTC | Nextcure Inc | $11.26M | +72.98% |
| CTNM | Contineum Therapeutics Inc - Class A | $11.31M | +73.70% |
| TVRD | Cara Therapeutics Inc | $11.31M | +73.76% |
| IMMX | Immix Biopharma Inc | $11.45M | +75.91% |
| ELVN | Enliven Therapeutics Inc | $11.49M | +76.45% |
| HYPD | Eyenovia Inc | $11.57M | +77.74% |
| AARD | Aardvark Therapeutics Inc | $11.60M | +78.25% |
| RPTX | Repare Therapeutics Inc | $11.62M | +78.49% |
| ZURA | Zura Bio Ltd - Class A | $11.74M | +80.41% |
| CVM | Cel-Sci Corp | $11.76M | +80.58% |
| BCLI | Brainstorm Cell Therapeutics Inc | $11.76M | +80.71% |
| ACOG | Alpha Cognition Inc | $11.79M | +81.13% |
| GHRS | GH Research PLC | $11.89M | +82.64% |
| CING | Cingulate Inc | $12.00M | +84.28% |
| IFRX | InflaRx N.V. | $12.01M | +84.52% |
| ACRV | Acrivon Therapeutics Inc | $12.32M | +89.20% |
| DSGN | Design Therapeutics Inc | $12.39M | +90.29% |
| CRVS | Corvus Pharmaceuticals Inc | $12.52M | +92.26% |
| TTRX | Turn Therapeutics Inc | $12.53M | +92.42% |
| RNAZ | TransCode Therapeutics Inc | $12.64M | +94.22% |
| ANVS | Annovis Bio Inc | $13.12M | +101.50% |
| ONCY | Oncolytics Biotech Inc | $13.29M | +104.16% |
| IMA | Ikena Oncology Inc | $13.36M | +105.15% |
| FULC | Fulcrum Therapeutics Inc | $13.47M | +106.87% |
| RAPT | RAPT Therapeutics Inc | $13.76M | +111.40% |
| UPB | Upstream Bio Inc | $14.06M | +115.96% |
| VTGN | VistaGen Therapeutics Inc | $14.14M | +117.14% |
| SNSE | Sensei Biotherapeutics Inc | $14.19M | +117.99% |
| LPTX | Leap Therapeutics Inc | $14.32M | +120.05% |
| CRDF | Cardiff Oncology Inc | $14.46M | +122.17% |
| DWTX | Virios Therapeutics Inc | $14.58M | +124.03% |
| TVGN | Tevogen Bio Holdings Inc | $14.76M | +126.78% |
| LBRX | LB Pharmaceuticals Inc | $14.79M | +127.17% |
| ZVSA | ZyVersa Therapeutics Inc | $14.87M | +128.36% |
| MBX | MBX Biosciences Inc | $14.95M | +129.57% |
| ICCC | Immucell Corp | $14.97M | +130.01% |
| CBIO | Crescent Biopharma Inc | $15.28M | +134.76% |
| AIM | AIM ImmunoTech Inc. | $15.56M | +139.09% |
| TECX | AvroBio Inc | $16.16M | +148.23% |
| RANI | Rani Therapeutics Holdings Inc Class A | $16.34M | +150.94% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $16.40M | +151.92% |
| PMCB | PharmaCyte Biotech Inc | $16.47M | +153.01% |
| NTHI | NeOnc Technologies Holdings Inc | $16.56M | +154.40% |
| RLMD | Relmada Therapeutics Inc | $16.63M | +155.46% |
| YDES | YD Bio Ltd | $16.64M | +155.53% |
| SION | Sionna Therapeutics Inc | $16.83M | +158.54% |
| CRIS | Curis Inc | $16.98M | +160.81% |
| ABUS | Arbutus Biopharma Corp | $16.99M | +160.94% |
| OSTX | OS Therapies Inc | $17.05M | +161.95% |
| QTTB | Q32 Bio Inc | $17.36M | +166.70% |
| CNTB | Connect Biopharma Holdings Ltd | $17.44M | +167.94% |
| BLRX | Bioline Rx Ltd | $17.56M | +169.73% |
| ORKA | ARCA biopharma Inc | $17.76M | +172.81% |
| JSPR | Jasper Therapeutics Inc | $17.78M | +173.18% |
| EVMN | Evommune Inc | $17.90M | +174.96% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $18.14M | +178.62% |
| TERN | Terns Pharmaceuticals Inc | $18.55M | +185.01% |
| CMPX | Compass Therapeutics Inc | $18.70M | +187.20% |
| LXEO | Lexeo Therapeutics Inc | $18.86M | +189.69% |
| MPLT | MapLight Therapeutics Inc | $18.95M | +191.15% |
| MOLN | Molecular Partners AG | $19.15M | +194.14% |
| LNAI | Lunai Bioworks Inc | $19.41M | +198.22% |
| VTYX | Ventyx Biosciences Inc | $20.10M | +208.77% |
| ACHV | Achieve Life Sciences Inc | $20.27M | +211.40% |
| GRDX | Entero Therapeutics Inc | $20.47M | +214.49% |
| ADTX | Aditxt Inc | $20.66M | +217.34% |
| PDSB | PDS Biotechnology Corporation | $20.77M | +219.05% |
| ARTV | Artiva Biotherapeutics Inc | $20.97M | +222.12% |
| ORIC | ORIC Pharmaceuticals Inc | $21.20M | +225.73% |
| SABS | SAB Biotherapeutics Inc | $21.22M | +225.99% |
| SPRB | Spruce Biosciences Inc | $21.52M | +230.54% |
| HCWB | HCW Biologics Inc | $21.58M | +231.49% |
| FBRX | Forte Biosciences Inc | $21.79M | +234.69% |
| ATHA | Athira Pharma Inc | $22.29M | +242.35% |
| PEPG | PepGen Inc | $22.32M | +242.78% |
| AKTX | Akari Therapeutics Plc | $22.69M | +248.53% |
| VRCA | Verrica Pharmaceuticals Inc | $22.73M | +249.17% |
| TOVX | Theriva Biologics Inc | $22.85M | +250.98% |
| JBIO | Jade Biosciences Inc | $22.97M | +252.86% |
| VANI | Vivani Medical Inc | $23.27M | +257.42% |
| PHVS | Pharvaris NV | $23.48M | +260.68% |
| ABSI | Absci Corp | $23.62M | +262.86% |
| GLTO | Galecto Inc | $23.84M | +266.19% |
| CSBR | Champions Oncology Inc | $24.07M | +269.72% |
| ELTX | Elicio Therapeutics Inc | $24.13M | +270.60% |
| ALDX | Aldeyra Therapeutics Inc | $24.33M | +273.68% |
| CMRX | Chimerix Inc | $24.33M | +273.72% |
| TYRA | Tyra Biosciences Inc | $24.46M | +275.81% |
| PASG | Passage Bio Inc | $24.71M | +279.57% |
| GYRE | Gyre Therapeutics Inc | $25.03M | +284.49% |
| AVBP | ArriVent BioPharma Inc | $25.32M | +288.86% |
| EWTX | Edgewise Therapeutics Inc | $25.32M | +288.92% |
| NGNE | Neoleukin Therapeutics Inc | $25.36M | +289.52% |
| AEON | AEON Biopharma Inc - Class A | $25.38M | +289.89% |
| BRNS | Barinthus Biotherapeutics Plc. | $25.66M | +294.24% |
| PHXM | PHAXIAM Therapeutics SA ADR | $25.70M | +294.70% |
| NRXP | NRX Pharmaceuticals Inc | $25.72M | +295.07% |
| LENZ | LENZ Therapeutics Inc | $26.04M | +300.05% |
| RAPP | Rapport Therapeutics Inc | $26.09M | +300.69% |
| ADAG | Adagene Inc | $26.36M | +304.97% |
| KROS | Keros Therapeutics Inc | $26.66M | +309.57% |
| UNCY | Unicycive Therapeutics Inc | $26.70M | +310.17% |
| ALXO | Alx Oncology Holdings Inc | $26.98M | +314.45% |
| DARE | Dare Bioscience Inc | $27.09M | +316.19% |
| HLVX | HilleVax Inc | $27.09M | +316.21% |
| HOOK | Hookipa Pharma Inc | $27.18M | +317.45% |
| AVIR | Atea Pharmaceuticals Inc | $27.18M | +317.56% |
| OVID | Ovid Therapeutics Inc | $27.36M | +320.26% |
| BMEA | Biomea Fusion Inc | $27.67M | +324.98% |
| ALLR | Allarity Therapeutics Inc | $28.00M | +330.15% |
| BOLT | Bolt Biotherapeutics Inc | $28.20M | +333.26% |
| DRTS | Alpha Tau Medical Ltd | $28.55M | +338.60% |
| BDTX | Black Diamond Therapeutics Inc | $28.62M | +339.66% |
| TNYA | Tenaya Therapeutics Inc | $28.88M | +343.64% |
| VTVT | vTv Therapeutics Inc - Class A | $28.95M | +344.72% |
| SLRN | Acelyrin Inc | $29.27M | +349.66% |
| ACET | Adicet Bio Inc | $29.32M | +350.34% |
| YMAB | Y-Mabs Therapeutics Inc | $29.72M | +356.50% |
| SEER | Seer Inc - Class A | $30.65M | +370.86% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $30.77M | +372.73% |
| OABI | OmniAb Inc | $31.00M | +376.25% |
| IMNM | Immunome Inc | $31.11M | +377.82% |
| PVLA | Palvella Therapeutics Inc | $31.45M | +383.04% |
| NAGE | Niagen Bioscience Inc | $32.00M | +391.54% |
| AURA | Aura Biosciences Inc | $32.52M | +399.49% |
| ALGS | Aligos Therapeutics Inc | $32.77M | +403.36% |
| ANRO | Alto Neuroscience Inc | $32.89M | +405.22% |
| PYXS | Pyxis Oncology Inc | $33.03M | +407.40% |
| PROK | ProKidney Corp - Class A | $33.27M | +411.06% |
| NAUT | Nautilus Biotechnology Inc | $33.36M | +412.50% |
| AVTX | Avalo Therapeutics Inc | $33.41M | +413.20% |
| FENC | Fennec Pharmaceuticals Inc | $34.15M | +424.53% |
| APLT | Applied Therapeutics Inc | $34.94M | +436.64% |
| PLX | Protalix BioTherapeutics Inc | $35.11M | +439.28% |
| SNTI | Senti Biosciences Inc | $35.68M | +448.02% |
| CGEM | Cullinan Oncology Inc | $36.81M | +465.47% |
| ASMB | Assembly Biosciences Inc | $36.90M | +466.79% |
| PRTA | Prothena Corporation plc | $37.28M | +472.63% |
| PLRX | Pliant Therapeutics Inc | $37.43M | +474.96% |
| APGE | Apogee Therapeutics Inc | $37.86M | +481.58% |
| IMUX | Immunic Inc | $38.51M | +491.54% |
| MDWD | MediWound Ltd | $38.56M | +492.30% |
| ATXS | Astria Therapeutics Inc | $38.61M | +493.13% |
| IVVD | Invivyd Inc | $38.69M | +494.35% |
| IOBT | IO Biotech Inc | $39.05M | +499.77% |
| LVTX | LAVA Therapeutics NV | $39.23M | +502.63% |
| CTMX | CytomX Therapeutics Inc | $39.41M | +505.44% |
| BCAX | Bicara Therapeutics Inc | $39.64M | +508.92% |
| ITRM | Iterum Therapeutics Plc | $39.88M | +512.66% |
| SAVA | Cassava Sciences Inc. | $40.23M | +517.91% |
| NBY | Stablecoin Development Corp | $40.92M | +528.54% |
| KLRS | Kalaris Therapeutics Inc | $41.25M | +533.61% |
| PTGX | Protagonist Therapeutics Inc | $41.99M | +544.95% |
| ATNM | Actinium Pharmaceuticals Inc | $43.13M | +562.58% |
| CGON | Cg Oncology Inc | $43.48M | +567.94% |
| INO | Inovio Pharmaceuticals Inc | $43.71M | +571.42% |
| TNGX | Tango Therapeutics Inc | $44.29M | +580.28% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $44.80M | +588.12% |
| CABA | Cabaletta Bio Inc | $44.84M | +588.80% |
| JAGX | Jaguar Health Inc | $45.11M | +592.98% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $45.37M | +596.87% |
| DNTH | Dianthus Therapeutics Inc | $45.57M | +600.00% |
| SVRA | Savara Inc | $45.61M | +600.55% |
| VYGR | Voyager Therapeutics Inc | $45.66M | +601.32% |
| MENS | Jyong Biotech Ltd | $45.68M | +601.75% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $45.81M | +603.66% |
| HOWL | Werewolf Therapeutics Inc | $45.82M | +603.84% |
| BCAB | BioAtla Inc | $45.88M | +604.69% |
| ABOS | Acumen Pharmaceuticals Inc | $46.15M | +608.96% |
| ELDN | Eledon Pharmaceuticals Inc | $46.21M | +609.82% |
| LYRA | Lyra Therapeutics Inc | $46.83M | +619.28% |
| CRBU | Caribou Biosciences Inc | $46.98M | +621.66% |
| OCS | Oculis Holding AG | $47.20M | +625.09% |
| RCKT | Rocket Pharmaceuticals Inc | $47.37M | +627.62% |
| CAPR | Capricor Therapeutics Inc | $47.58M | +630.89% |
| AKRO | Akero Therapeutics Inc | $47.94M | +636.41% |
| IMMP | Immutep Ltd | $48.30M | +641.98% |
| STOK | Stoke Therapeutics Inc | $48.40M | +643.47% |
| BYSI | BeyondSpring Inc | $48.76M | +649.00% |
| SLDB | Solid Biosciences Inc | $48.76M | +649.02% |
| XENE | Xenon Pharmaceuticals Inc | $48.99M | +652.55% |
| OBIO | Orchestra BioMed Holdings Inc | $49.69M | +663.33% |
| OLMA | Olema Pharmaceuticals Inc | $50.17M | +670.61% |
| PRAX | Praxis Precision Medicines Inc | $50.24M | +671.75% |
| LRMR | Larimar Therapeutics Inc | $50.48M | +675.39% |
| OTLK | Outlook Therapeutics Inc | $50.89M | +681.68% |
| OCGN | Ocugen Inc | $51.10M | +684.95% |
| ABEO | Abeona Therapeutics Inc | $53.55M | +722.66% |
| ARCT | Arcturus Therapeutics Holdings Inc | $54.05M | +730.25% |
| BOLD | Boundless Bio Inc | $54.59M | +738.51% |
| CLDX | Celldex Therapeutics Inc | $55.03M | +745.28% |
| ALT | Altimmune Inc | $55.04M | +745.42% |
| ACRS | Aclaris Therapeutics Inc | $55.07M | +745.94% |
| ENGN | enGene Holdings Inc | $55.57M | +753.56% |
| LCTX | Lineage Cell Therapeutics Inc | $56.84M | +773.09% |
| ATRA | Atara Biotherapeutics Inc | $57.31M | +780.32% |
| RLAY | Relay Therapeutics Inc | $57.43M | +782.18% |
| EYPT | EyePoint Pharmaceuticals Inc | $57.74M | +787.02% |
| RNA | Atrium Therapeutics Inc | $58.26M | +794.87% |
| ANNX | Annexon Inc | $58.35M | +796.39% |
| DBVT | DBV Technologies | $58.40M | +797.08% |
| MGX | Metagenomi Inc | $59.17M | +808.88% |
| PRLD | Prelude Therapeutics Inc | $59.46M | +813.35% |
| GPCR | Structure Therapeutics Inc | $61.03M | +837.48% |
| FDMT | 4D Molecular Therapeutics Inc | $61.07M | +838.08% |
| KYTX | Kyverna Therapeutics Inc | $61.44M | +843.84% |
| PRQR | ProQR Therapeutics N.V | $61.50M | +844.70% |
| IRON | Disc Medicine Inc | $61.78M | +849.06% |
| IPSC | Century Therapeutics Inc | $61.81M | +849.45% |
| CASI | CASI Pharmaceuticals Inc | $62.93M | +866.70% |
| CTXR | Citius Pharmaceuticals Inc | $63.46M | +874.75% |
| CADL | Candel Therapeutics Inc | $63.89M | +881.43% |
| KRRO | Korro Bio Inc | $63.99M | +882.93% |
| PBYI | Puma Biotechnology Inc | $64.28M | +887.45% |
| TRDA | Entrada Therapeutics Inc | $64.66M | +893.30% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $65.59M | +907.54% |
| SLN | Silence Therapeutics Plc | $65.72M | +909.54% |
| MDXG | Mimedx Group Inc | $65.74M | +909.83% |
| LXRX | Lexicon Pharmaceuticals Inc | $65.96M | +913.26% |
| ATAI | ATAI Life Sciences N.V. | $66.10M | +915.33% |
| DAWN | Day One Biopharmaceuticals Inc | $66.67M | +924.04% |
| NAMS | NewAmsterdam Pharma Company NV | $67.42M | +935.65% |
| ERAS | Erasca Inc | $67.71M | +940.03% |
| DTIL | Precision Biosciences Inc | $67.79M | +941.32% |
| ZNTL | Zentalis Pharmaceuticals Inc | $70.39M | +981.20% |
| GBIO | Generation Bio Company | $71.34M | +995.79% |
| WVE | Wave Life Sciences Ltd | $71.81M | +1003.13% |
| ZVRA | Zevra Therapeutics Inc | $72.78M | +1017.90% |
| CAMP | CAMP4 Therapeutics Corp | $74.56M | +1045.24% |
| AGIO | Agios Pharmaceuticals Inc | $75.88M | +1065.51% |
| LYEL | Lyell Immunopharma Inc | $76.96M | +1082.20% |
| GUTS | Fractyl Health Inc | $78.01M | +1098.28% |
| MAZE | Maze Therapeutics Inc | $78.01M | +1098.29% |
| SGMO | Sangamo Therapeutics Inc | $78.92M | +1112.29% |
| NMRA | Neumora Therapeutics Inc | $83.20M | +1177.99% |
| IPHA | Innate Pharma | $84.39M | +1196.27% |
| VXRT | Vaxart Inc | $85.94M | +1220.09% |
| CDXS | Codexis Inc | $86.14M | +1223.13% |
| NKTX | Nkarta Inc | $86.21M | +1224.32% |
| JANX | Janux Therapeutics Inc | $86.69M | +1231.64% |
| IMTX | Immatics N.V | $87.55M | +1244.92% |
| IRD | Ocuphire Pharma Inc | $87.89M | +1250.03% |
| TSHA | Taysha Gene Therapies Inc | $88.41M | +1258.02% |
| TIL | Instil Bio Inc | $89.73M | +1278.34% |
| XLO | Xilio Therapeutics Inc | $90.94M | +1296.96% |
| MCRB | Seres Therapeutics Inc | $91.12M | +1299.68% |
| IDYA | Ideaya Biosciences Inc | $93.08M | +1329.82% |
| SYRE | Spyre Therapeutics Inc | $93.14M | +1330.75% |
| CCCC | C4 Therapeutics Inc | $94.61M | +1353.36% |
| CDTX | Cidara Therapeutics Inc | $96.26M | +1378.69% |
| BCYC | Bicycle Therapeutics Plc | $98.08M | +1406.54% |
| XFOR | X4 Pharmaceuticals Inc | $101.83M | +1464.22% |
| SMMT | Summit Therapeutics Inc | $101.92M | +1465.65% |
| IMVT | Immunovant Inc | $104.42M | +1504.02% |
| ALMS | Alumis Inc | $104.57M | +1506.25% |
| RIGL | Rigel Pharmaceuticals | $104.71M | +1508.46% |
| ACIU | AC Immune SA | $105.89M | +1526.53% |
| VKTX | Viking Therapeutics Inc | $106.33M | +1533.26% |
| PTHS | Channel Therapeutics Corporation | $110.28M | +1593.95% |
| SLNO | Soleno Therapeutics Inc | $112.59M | +1629.46% |
| THAR | Tharimmune Inc | $114.86M | +1664.29% |
| ALLO | Allogene Therapeutics Inc | $117.08M | +1698.51% |
| ABVX | Abivax | $117.55M | +1705.65% |
| TCRX | Tscan Therapeutics Inc | $118.20M | +1715.73% |
| PGEN | Precigen Inc | $118.39M | +1718.62% |
| FGEN | FibroGen Inc | $118.92M | +1726.71% |
| KRYS | Krystal Biotech Inc | $120.24M | +1746.97% |
| CRNX | Crinetics Pharmaceuticals Inc | $120.68M | +1753.72% |
| VERA | Vera Therapeutics Inc - Class A | $122.04M | +1774.69% |
| MRSN | Mersana Therapeutics Inc | $122.22M | +1777.47% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $122.44M | +1780.86% |
| REPL | Replimune Group Inc | $123.05M | +1790.18% |
| ADVM | Adverum Biotechnologies Inc | $128.05M | +1867.04% |
| MRUS | Merus N.V | $129.26M | +1885.62% |
| KYMR | Kymera Therapeutics Inc | $129.38M | +1887.39% |
| VCEL | Vericel Corp | $129.40M | +1887.65% |
| CPRX | Catalyst Pharmaceuticals Inc | $134.91M | +1972.40% |
| NTLA | Intellia Therapeutics Inc | $137.84M | +2017.36% |
| EDIT | Editas Medicine Inc | $144.93M | +2126.27% |
| CELU | Celularity Inc - Class A | $145.39M | +2133.35% |
| GALT | Galectin Therapeutics Inc | $146.00M | +2142.64% |
| VSTM | Verastem Inc | $146.03M | +2143.18% |
| MLTX | MoonLake Immunotherapeutics - Class A | $146.35M | +2148.08% |
| OCUL | Ocular Therapeutix Inc | $150.96M | +2218.82% |
| NBTX | Nanobiotix | $152.24M | +2238.60% |
| VNDA | Vanda Pharmaceuticals Inc | $152.76M | +2246.54% |
| VRDN | Viridian Therapeutics Inc | $153.01M | +2250.37% |
| CNTA | Centessa Pharmaceuticals plc | $154.41M | +2271.97% |
| FBIO | Fortress Biotech Inc | $154.50M | +2273.27% |
| NRIX | Nurix Therapeutics Inc | $155.24M | +2284.59% |
| AUPH | Aurinia Pharmaceuticals Inc | $156.37M | +2302.01% |
| NUVL | Nuvalent Inc - Class A | $156.78M | +2308.31% |
| MIST | Milestone Pharmaceuticals Inc | $157.69M | +2322.20% |
| XOMA | XOMA Corp | $158.96M | +2341.83% |
| GLPG | Galapagos NV | $170.58M | +2520.24% |
| CORT | Corcept Therapeutics Inc | $176.89M | +2617.27% |
| PRTC | PureTech Health plc American Depositary Shares | $184.22M | +2729.75% |
| NKTR | Nektar Therapeutics | $187.06M | +2773.35% |
| MESO | Mesoblast Ltd | $187.24M | +2776.21% |
| CHRS | Coherus Biosciences Inc | $187.40M | +2778.63% |
| IVA | Inventiva | $187.87M | +2785.81% |
| SEPN | Septerna Inc | $191.23M | +2837.48% |
| KOD | Kodiak Sciences Inc | $193.91M | +2878.57% |
| MGNX | Macrogenics Inc | $196.68M | +2921.12% |
| ENTA | Enanta Pharmaceuticals Inc | $198.12M | +2943.27% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $201.59M | +2996.64% |
| ACLX | Arcellx Inc | $201.64M | +2997.37% |
| IOVA | Iovance Biotherapeutics Inc | $203.91M | +3032.27% |
| RYTM | Rhythm Pharmaceuticals Inc | $204.70M | +3044.39% |
| INBX | Inhibrx Biosciences Inc | $205.00M | +3049.03% |
| VIR | Vir Biotechnology Inc | $212.82M | +3169.12% |
| GLUE | Monte Rosa Therapeutics Inc | $214.51M | +3195.12% |
| DYN | Dyne Therapeutics Inc | $214.90M | +3201.00% |
| PRME | Prime Medicine Inc | $218.03M | +3249.16% |
| PHAR | Pharming Group N.V. | $220.41M | +3285.65% |
| XNCR | Xencor Inc | $221.21M | +3298.05% |
| SPRY | ARS Pharmaceuticals Inc | $226.26M | +3375.62% |
| CLLS | Cellectis | $229.27M | +3421.75% |
| ALEC | Alector Inc | $229.53M | +3425.87% |
| TARS | Tarsus Pharmaceuticals Inc | $232.18M | +3466.57% |
| HRTX | Heron Therapeutics Inc | $237.08M | +3541.77% |
| SANA | Sana Biotechnology Inc | $254.35M | +3807.11% |
| SRRK | Scholar Rock Holding Corp | $259.24M | +3882.20% |
| ARVN | Arvinas Inc | $260.70M | +3904.61% |
| CVAC | CureVac N.V. | $267.39M | +4007.36% |
| ARQT | Arcutis Biotherapeutics Inc | $270.36M | +4052.92% |
| ADMA | Adma Biologics Inc | $274.86M | +4122.10% |
| CBUS | Cibus Global Ltd. Class A | $288.72M | +4335.05% |
| GOSS | Gossamer Bio Inc | $290.38M | +4360.55% |
| NUVB | Nuvation Bio Inc - Class A | $290.68M | +4365.08% |
| VRNA | Verona Pharma Plc | $294.60M | +4425.31% |
| COGT | Cogent Biosciences Inc | $295.31M | +4436.30% |
| VALN | Valneva SE | $295.31M | +4436.31% |
| FHTX | Foghorn Therapeutics Inc | $298.57M | +4486.41% |
| MGTX | MeiraGTx Holdings plc | $302.79M | +4551.08% |
| GERN | Geron Corp | $305.01M | +4585.28% |
| STRO | Sutro Biopharma Inc | $308.88M | +4644.62% |
| OPT | Opthea Ltd | $314.48M | +4730.65% |
| ZYME | Zymeworks BC Inc | $314.63M | +4732.96% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $314.75M | +4734.92% |
| BEAM | Beam Therapeutics Inc | $316.36M | +4759.60% |
| RGNX | Regenxbio Inc | $320.81M | +4827.99% |
| BHVN | Biohaven Ltd | $336.91M | +5075.21% |
| DNLI | Denali Therapeutics Inc | $339.93M | +5121.58% |
| NERV | Minerva Neurosciences Inc | $343.08M | +5170.03% |
| KALV | KalVista Pharmaceuticals Inc | $348.57M | +5254.36% |
| PCVX | Vaxcyte Inc | $352.29M | +5311.58% |
| ARDX | Ardelyx Inc | $355.88M | +5366.74% |
| CELC | Celcuity Inc | $356.64M | +5378.33% |
| ACAD | Acadia Pharmaceuticals Inc | $357.16M | +5386.39% |
| HRMY | Harmony Biosciences Holdings Inc | $361.48M | +5452.61% |
| ABCL | AbCellera Biologics Inc | $369.03M | +5568.65% |
| URGN | UroGen Pharma Ltd | $377.94M | +5705.58% |
| CRMD | CorMedix Inc | $378.59M | +5715.48% |
| ARMP | Armata Pharmaceuticals Inc | $381.39M | +5758.46% |
| ENLV | Enlivex Therapeutics Ltd | $392.05M | +5922.27% |
| KPTI | Karyopharm Therapeutics Inc | $397.06M | +5999.28% |
| SRZN | Surrozen Inc | $398.86M | +6026.82% |
| ZBIO | Zenas Biopharma Inc | $411.85M | +6226.47% |
| ROIV | Roivant Sciences Ltd | $416.27M | +6294.39% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $417.33M | +6310.63% |
| AUTL | Autolus Therapeutics plc | $418.24M | +6324.56% |
| SNDX | Syndax Pharmaceuticals Inc | $431.05M | +6521.29% |
| ZLAB | Zai Lab Ltd | $433.76M | +6562.92% |
| RNAC | Cartesian Therapeutics Inc | $436.51M | +6605.21% |
| TVTX | Travere Therapeutics Inc | $456.46M | +6911.67% |
| ADCT | Adc Therapeutics SA | $507.87M | +7701.43% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $534.78M | +8114.79% |
| KURA | Kura Oncology Inc | $544.67M | +8266.64% |
| CAI | Caris Life Sciences Inc - Class A | $568.90M | +8638.83% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $589.92M | +8961.78% |
| RVNC | Revance Therapeutics Inc | $624.59M | +9494.38% |
| LEGN | Legend Biotech Corp | $629.02M | +9562.36% |
| QURE | uniQure N.V. | $629.36M | +9567.63% |
| PHAT | Phathom Pharmaceuticals Inc | $642.08M | +9762.90% |
| MIRM | Mirum Pharmaceuticals Inc | $648.42M | +9860.40% |
| VOR | Vor Biopharma Inc | $657.17M | +9994.78% |
| EXEL | Exelixis Inc | $657.85M | +10005.15% |
| AXSM | Axsome Therapeutics Inc | $659.02M | +10023.20% |
| APLS | Apellis Pharmaceuticals Inc | $667.61M | +10155.13% |
| FOLD | Amicus Therapeutics Inc | $675.63M | +10278.33% |
| IMCR | Immunocore Holdings plc | $678.42M | +10321.23% |
| MDGL | Madrigal Pharmaceuticals Inc | $683.87M | +10404.96% |
| RCUS | Arcus Biosciences Inc | $695.12M | +10577.74% |
| RVMD | Revolution Medicines Inc | $753.82M | +11479.42% |
| MNKD | Mannkind Corp | $803.60M | +12244.06% |
| NBP | NovaBridge Biosciences. | $894.81M | +13645.18% |
| CRSP | CRISPR Therapeutics AG | $911.26M | +13897.91% |
| TGTX | TG Therapeutics Inc | $945.71M | +14426.97% |
| TLX | Telix Pharmaceuticals Ltd | $1.15B | +17544.24% |
| NVAX | Novavax Inc | $1.19B | +18147.68% |
| ARGX | Argen X SE | $1.36B | +20784.88% |
| INSM | Insmed Inc | $1.37B | +20960.08% |
| IBRX | ImmunityBio Inc | $1.52B | +23183.61% |
| ASND | Ascendis Pharma A/S | $1.52B | +23200.86% |
| RARE | Ultragenyx Pharmaceutical Inc | $1.52B | +23325.50% |
| SRPT | Sarepta Therapeutics Inc | $1.67B | +25611.71% |
| INCY | Incyte Corp | $1.72B | +26263.53% |
| SVA | Sinovac Biotech Ltd | $2.04B | +31295.56% |
| CYTK | Cytokinetics Inc | $2.10B | +32158.77% |
| FTRE | FORTE SOFTWARE INC | $2.16B | +33041.32% |
| BNTX | BioNTech SE | $2.38B | +36440.37% |
| BMRN | Biomarin Pharmaceutical Inc | $2.38B | +36442.38% |
| HALO | Halozyme Therapeutics Inc | $2.45B | +37581.77% |
| AAPG | Ascentage Pharma Group International | $2.63B | +40315.35% |
| IONS | Ionis Pharmaceuticals Inc | $2.96B | +45346.31% |
| PTCT | PTC Therapeutics Inc | $3.05B | +46744.38% |
| BBIO | BridgeBio Pharma Inc | $3.64B | +55811.77% |
| ONC | BeiGene Ltd | $3.79B | +58166.93% |
| MRNA | Moderna Inc | $4.08B | +62572.81% |
| ALNY | Alnylam Pharmaceuticals Inc | $4.18B | +64065.21% |
| GMAB | Genmab | $6.69B | +102724.76% |
| VRTX | Vertex Pharmaceuticals Inc | $7.12B | +109308.60% |
| REGN | Regeneron Pharmaceuticals Inc | $9.45B | +144987.56% |
| RPRX | Royalty Pharma plc - Class A | $9.88B | +151644.73% |